Cystic fibrosis, genetics, and DNA technology.
Advances in molecular genetics are leading to changes in practice that have a direct impact on the obstetrician and gynecologist. New techniques of prenatal screening, diagnosis, and potentially therapy are rapidly evolving. Recent developments in cystic fibrosis, preimplantation genetics, fragile X syndrome, neurofibromatosis, muscular dystrophy, and Marfan syndrome are discussed.
Nugent
C E
CE
University of Michigan Medical Center, Ann Arbor.
D003550:Cystic Fibrosis / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D005315:Fetal Diseases / Q000175:diagnosis* / Q000235:genetics / Q000628:therapy; D005600:Fragile X Syndrome / Q000175:diagnosis / Q000235:genetics; D005819:Genetic Markers; D006801:Humans; D008382:Marfan Syndrome / Q000175:diagnosis / Q000235:genetics; D008967:Molecular Biology; D009136:Muscular Dystrophies / Q000175:diagnosis / Q000235:genetics; D009456:Neurofibromatosis 1 / Q000175:diagnosis / Q000235:genetics; D011296:Prenatal Diagnosis
D005819:Genetic Markers